Replies to post #105763 on Biotech Values

[Rocky3]

So using 70% margin (offsetting the less than 50% profit sharing) and 50% NVS payback, I get around $4MM net, or .08/sh. Anything positive will be great.

And next quarter will be much better, followed by blow-out numbers once the NVS payback is over (assuming that Teva approval does not come).